Carlos Gomez‐Roca
- Oncology top 1%
- Molecular Biology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 5%
- Surgery top 5%
- Co-authors
- Jean‐Pierre DelordJean‐Charles SoriaSarina A. Piha‐PaulSanatan SarafBert H. O’NeilEmilie M.J. van BrummelenPatrick A. OttAndréa Varga
- Topics
- Cancer Immunotherapy and Biomarkers (46 papers)Colorectal Cancer Treatments and Studies (26 papers)Cancer Genomics and Diagnostics (22 papers)
- Cited by
- OncologyImmunologyHematology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Carlos Gomez‐Roca
144 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 2.4k
- Molecular Biology 1.3k
- Pulmonary and Respiratory Medicine 820
- Immunology 796
- Surgery 639
Countries citing papers authored by Carlos Gomez‐Roca
This map shows the geographic impact of Carlos Gomez‐Roca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Gomez‐Roca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Gomez‐Roca more than expected).
Fields of papers citing papers by Carlos Gomez‐Roca
This network shows the impact of papers produced by Carlos Gomez‐Roca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Gomez‐Roca. The network helps show where Carlos Gomez‐Roca may publish in the future.
Co-authorship network of co-authors of Carlos Gomez‐Roca
This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Gomez‐Roca. A scholar is included among the top collaborators of Carlos Gomez‐Roca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Gomez‐Roca. Carlos Gomez‐Roca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 8 | |
| 3 | 32 | |
| 4 | 2 | |
| 5 | 11 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 9 | |
| 9 | 3 | |
| 10 | 95 | |
| 11 | 22 | |
| 12 | 8 | |
| 13 | 10 | |
| 14 | 59 | |
| 15 | Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trialbreakdown → | 386 |
| 16 | 21 | |
| 17 | 268 | |
| 18 | 14 | |
| 19 | 130 | |
| 20 | 4 |
About Carlos Gomez‐Roca
Carlos Gomez‐Roca is a scholar working on Oncology, Cancer Research and Biological Psychiatry, having authored 147 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (46 papers), Colorectal Cancer Treatments and Studies (26 papers) and Cancer Genomics and Diagnostics (22 papers). The work is most often cited by research in Oncology (2.4k citations), Immunology (796 citations) and Hematology (401 citations). Carlos Gomez‐Roca has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Jean‐Pierre Delord, Jean‐Charles Soria, Sarina A. Piha‐Paul, Sanatan Saraf, Bert H. O’Neil, Emilie M.J. van Brummelen, Patrick A. Ott, Andréa Varga, Christophe Le Tourneau and Jean‐Sébastien Frenel. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.